A detailed history of Los Angeles Capital Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 276,881 shares of VNDA stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
276,881
Previous 324,961 14.8%
Holding current value
$1.28 Million
Previous $1.84 Million 29.3%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$4.61 - $6.34 $221,648 - $304,827
-48,080 Reduced 14.8%
276,881 $1.3 Million
Q2 2024

Aug 05, 2024

SELL
$3.91 - $6.5 $415,488 - $690,709
-106,263 Reduced 24.64%
324,961 $1.84 Million
Q1 2024

Apr 05, 2024

BUY
$3.47 - $4.61 $224,404 - $298,128
64,670 Added 17.64%
431,224 $1.77 Million
Q4 2023

Feb 06, 2024

SELL
$3.38 - $4.58 $335,972 - $455,252
-99,400 Reduced 21.33%
366,554 $1.55 Million
Q3 2023

Nov 06, 2023

BUY
$4.28 - $6.57 $591,855 - $908,525
138,284 Added 42.2%
465,954 $2.01 Million
Q2 2023

Aug 03, 2023

BUY
$5.9 - $6.95 $528,315 - $622,337
89,545 Added 37.6%
327,670 $2.16 Million
Q1 2023

May 04, 2023

BUY
$6.18 - $7.99 $1.05 Million - $1.36 Million
169,768 Added 248.35%
238,125 $1.62 Million
Q4 2022

Feb 06, 2023

SELL
$6.87 - $10.96 $10,435 - $16,648
-1,519 Reduced 2.17%
68,357 $505,000
Q3 2022

Nov 02, 2022

SELL
$9.44 - $11.76 $18,880 - $23,520
-2,000 Reduced 2.78%
69,876 $690,000
Q2 2022

Aug 05, 2022

SELL
$9.31 - $11.84 $97,931 - $124,544
-10,519 Reduced 12.77%
71,876 $783,000
Q4 2021

Feb 03, 2022

BUY
$15.69 - $21.14 $392 - $528
25 Added 0.03%
82,395 $1.29 Million
Q3 2021

Nov 08, 2021

BUY
$15.35 - $21.27 $436,262 - $604,514
28,421 Added 52.68%
82,370 $1.41 Million
Q2 2021

Aug 05, 2021

SELL
$15.71 - $21.51 $105,728 - $144,762
-6,730 Reduced 11.09%
53,949 $1.16 Million
Q1 2021

May 05, 2021

SELL
$13.42 - $20.28 $413,322 - $624,603
-30,799 Reduced 33.67%
60,679 $911,000
Q4 2020

Feb 04, 2021

SELL
$9.77 - $13.81 $11,968 - $16,917
-1,225 Reduced 1.32%
91,478 $1.2 Million
Q3 2020

Nov 02, 2020

SELL
$9.32 - $12.02 $537,400 - $693,085
-57,661 Reduced 38.35%
92,703 $896,000
Q2 2020

Aug 05, 2020

SELL
$9.66 - $12.02 $591,848 - $736,441
-61,268 Reduced 28.95%
150,364 $1.72 Million
Q1 2020

May 04, 2020

SELL
$7.5 - $16.8 $469,815 - $1.05 Million
-62,642 Reduced 22.84%
211,632 $2.19 Million
Q4 2019

Feb 07, 2020

BUY
$12.38 - $17.47 $505,846 - $713,824
40,860 Added 17.51%
274,274 $4.5 Million
Q3 2019

Nov 07, 2019

BUY
$12.27 - $15.79 $2.43 Million - $3.13 Million
197,952 Added 558.21%
233,414 $3.1 Million
Q2 2019

Jul 29, 2019

SELL
$13.37 - $18.85 $23,263 - $32,799
-1,740 Reduced 4.68%
35,462 $500,000
Q1 2019

Apr 25, 2019

SELL
$17.59 - $31.05 $794,188 - $1.4 Million
-45,150 Reduced 54.83%
37,202 $685,000
Q4 2018

Feb 11, 2019

SELL
$18.97 - $31.47 $227,450 - $377,325
-11,990 Reduced 12.71%
82,352 $2.15 Million
Q3 2018

Nov 05, 2018

BUY
$18.25 - $23.0 $1.03 Million - $1.3 Million
56,620 Added 150.1%
94,342 $2.17 Million
Q1 2018

Apr 27, 2018

BUY
$14.05 - $20.2 $1,756 - $2,525
125 Added 0.33%
37,722 $636,000
Q4 2017

Feb 05, 2018

BUY
$12.85 - $18.1 $284,049 - $400,100
22,105 Added 142.69%
37,597 $571,000
Q3 2017

Nov 06, 2017

BUY
$15.4 - $18.85 $238,576 - $292,024
15,492
15,492 $277,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $262M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.